Clinical Trial Update: Cognitive Enhancement Therapy for Early-Stage Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Cognitive Enhancement Therapy for early-stage schizophrenia has completed. The sponsor listed is Beth Israel Deaconess Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED